Architect of the President’s House plans to oppose the Trump administration’s possible removal of an upcoming exhibit next month.
|

Architect of the President’s House plans to oppose the Trump administration’s possible removal of an upcoming exhibit next month.

Discover how designer Troy C. Leonard expressed concern over the preservation of exhibits at the President’s House, highlighting the challenges faced under the current administration. Learn more about the impact on historical sites and the importance of safeguarding our heritage.

New indictments reveal extensive bribery scheme involving crab cakes, cash, and television connections tied to Adams’ close associate.
|

New indictments reveal extensive bribery scheme involving crab cakes, cash, and television connections tied to Adams’ close associate.

Discover the intriguing world of bribes involving comped catering for government events, celebrity appearances, free home renovations, and cash incentives. Uncover the secrets behind these enticing offers.

Philadelphia school officials discuss SEPTA’s impact and vote to initiate the closure of two city charter schools.
|

Philadelphia school officials discuss SEPTA’s impact and vote to initiate the closure of two city charter schools.

Discover how upcoming SEPTA service cuts could impact Philadelphia schools’ academic progress, as highlighted by Superintendent Tony B. Watlington during a recent school board meeting. Learn more about the implications for students and education in the city.

Fashion District seeks outside assistance to fill empty storefronts amid ongoing challenges.
|

Fashion District seeks outside assistance to fill empty storefronts amid ongoing challenges.

Discover the challenges facing the Fashion District of Philadelphia since its opening, including the impact of the COVID-19 pandemic on foot traffic and its ongoing transformation. Explore the future of this retail destination and what’s in store for shoppers.

Interius BioTherapeutics, a company spun out from Penn, is being acquired by Kite Pharma for 0 million.
|

Interius BioTherapeutics, a company spun out from Penn, is being acquired by Kite Pharma for 0 million.

Discover how a University of Pennsylvania spinout is revolutionizing cancer treatment through cost-effective and rapid immune cell modifications. Gilead Sciences Inc. is acquiring this innovative company for 0 million, marking a significant advancement in cancer therapy.